Semaglutide vs Tirzepatide — Comparing Compounded GLP-1 Medications
Compounded by licensed U.S. pharmacies • Shipped direct-to-door • No insurance required
Semaglutide and Tirzepatide are the two compounded GLP-1 medications offered through Alpha 1 Labs. Both support appetite regulation and weight loss, but they differ in mechanism. Semaglutide is a GLP-1 receptor agonist; Tirzepatide is a dual GIP and GLP-1 receptor agonist. A licensed provider determines which is appropriate based on your history and goals.
Physician-Directed
Eligibility determined by a licensed provider following clinical evaluation.
U.S. Compounded
Prepared by licensed U.S. 503A pharmacies pursuant to a valid prescription.
Direct-to-Door
Cold-chain delivery nationwide. No clinic visit required to begin.
Explore Related Options
Browse the treatments and resources connected to this program.
Frequently Asked Questions
Semaglutide activates only the GLP-1 receptor. Tirzepatide activates both the GLP-1 and GIP receptors, which may offer additional metabolic signaling. Both reduce appetite and support weight loss; a provider chooses based on your individual profile.
Start With a Telehealth Consultation
Eligibility is determined by a licensed provider following a clinical evaluation. No insurance required. Available nationwide.